In 2024, Conmed's return on assets (ROA) was 0.03, a -179.89% increase from the -0.04 ROA in the previous year.

Conmed Aktienanalyse

What does Conmed do?

Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Conmed's Return on Assets (ROA)

Conmed's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Conmed's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Conmed's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Conmed’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Conmed stock

What is the Return on Assets (ROA) of Conmed this year?

The Return on Assets (ROA) of Conmed is 0.03 undefined this year.

What was the ROA of Conmed compared to the previous year?

The ROA of Conmed has increased by -179.89% compared to the previous year.

What consequences do high ROA have for investors of Conmed?

A high ROA is advantageous for investors of Conmed, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Conmed?

A low ROA can be unfavorable for investors of Conmed as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Conmed affect the company?

An increase in ROA of Conmed can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Conmed impact the company?

A reduction in the ROA of Conmed can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Conmed?

Some factors that can influence the ROA of Conmed include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Conmed important for investors?

The ROA of Conmed is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Conmed take to improve ROA?

To improve ROA, Conmed can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Conmed pay?

Over the past 12 months, Conmed paid a dividend of 0.8 USD . This corresponds to a dividend yield of about 1.14 %. For the coming 12 months, Conmed is expected to pay a dividend of 0.8 USD.

What is the dividend yield of Conmed?

The current dividend yield of Conmed is 1.14 %.

When does Conmed pay dividends?

Conmed pays a quarterly dividend. This is distributed in the months of April, July, October, January.

How secure is the dividend of Conmed?

Conmed paid dividends every year for the past 16 years.

What is the dividend of Conmed?

For the upcoming 12 months, dividends amounting to 0.8 USD are expected. This corresponds to a dividend yield of 1.14 %.

In which sector is Conmed located?

Conmed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Conmed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Conmed from 1/3/2025 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Conmed pay the last dividend?

The last dividend was paid out on 1/3/2025.

What was the dividend of Conmed in the year 2023?

In the year 2023, Conmed distributed 0.8 USD as dividends.

In which currency does Conmed pay out the dividend?

The dividends of Conmed are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Conmed

Our stock analysis for Conmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.